Neurofibromatosis type 1 MRI
Jump to navigation
Jump to search
|
Neurofibromatosis type 1 Microchapters |
|
Differentiating Neurofibromatosis type 1 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Neurofibromatosis type 1 MRI On the Web |
|
American Roentgen Ray Society Images of Neurofibromatosis type 1 MRI |
|
Risk calculators and risk factors for Neurofibromatosis type 1 MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.
Overview
There are no CT scan findings associated with neurofibromatosis type 1, however, a MRI may be helpful in the diagnosis of complications. MRI is the preferred study method when studying the central nervous system (CNS). The use of routine screening brain MRI in patients with neurofibromatosis type 1 is controversial.
MRI
- There are no MRI findings associated with neurofibromatosis type 1.[1] However, a MRI may be helpful in the diagnosis of complications of neurofibromatosis type 1, which include:
- Optic pathway gliomas. Early detection may prevent vision loss and improve outcomes.[2]
- Intracranial mases[3]
- Vascular tumors[4]
- Chiari malformations[3]
- Pheochromocytomas[3][5]
- Benign hamartomas[3]
- Changes in ventricular size and hydrocephalus[3]
- Mediastinal tumors[3]
- Spinal cord masses[3]
- Deep plexiform neurofibromas[6]
- MRI is the preferred study method when studying the central nervous system (CNS).
- The use of routine screening brain MRI in patients with neurofibromatosis type 1 is controversial. Many physicians prefer to order a MRI at the moment of the diagnosis and repeat later only if suspicious symptoms arise[3]
References
- ↑ "Neurofibromatosis type 1: a multidisciplinary approach to care - ScienceDirect".
- ↑ Listernick R, Louis DN, Packer RJ, Gutmann DH (February 1997). "Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force". Ann. Neurol. 41 (2): 143–9. doi:10.1002/ana.410410204. PMID 9029062.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7
- ↑
- ↑ Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F (December 2007). "Pheochromocytoma: an update on genetics and management". Endocr. Relat. Cancer. 14 (4): 935–56. doi:10.1677/ERC-07-0142. PMID 18045948.
- ↑ Matsumine A, Kusuzaki K, Nakamura T, Nakazora S, Niimi R, Matsubara T, Uchida K, Murata T, Kudawara I, Ueda T, Naka N, Araki N, Maeda M, Uchida A (July 2009). "Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI". J. Cancer Res. Clin. Oncol. 135 (7): 891–900. doi:10.1007/s00432-008-0523-y. PMID 19101731.